Treatment with soluble activin type IIB-receptor improves bone mass and strength in a mouse model of Duchenne muscular dystrophy

MLA

Tero, Puolakkainen, et al. “Treatment with Soluble Activin Type IIB-Receptor Improves Bone Mass and Strength in a Mouse Model of Duchenne Muscular Dystrophy.” BMC Musculoskeletal Disorders, vol. 18, no. 1, July 2016. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........bd22f28d0b95eca812c50b63983a4cad&authtype=sso&custid=ns315887.

APA

Tero, P., Hongqian, M., Heikki, K., Arja, P., Timo, R., Olli, R., Kristiina, H., Juha J, H., & Riku, K. (2016). Treatment with soluble activin type IIB-receptor improves bone mass and strength in a mouse model of Duchenne muscular dystrophy. BMC Musculoskeletal Disorders, 18(1).

Chicago

Tero, Puolakkainen, Ma Hongqian, Kainulainen Heikki, Pasternack Arja, Rantalainen Timo, Ritvos Olli, Heikinheimo Kristiina, Hulmi Juha J, and Kiviranta Riku. 2016. “Treatment with Soluble Activin Type IIB-Receptor Improves Bone Mass and Strength in a Mouse Model of Duchenne Muscular Dystrophy.” BMC Musculoskeletal Disorders 18 (1). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........bd22f28d0b95eca812c50b63983a4cad&authtype=sso&custid=ns315887.